Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,801,184
  • Shares Outstanding, K 79,425
  • Annual Sales, $ 4,304 M
  • Annual Income, $ 1,059 M
  • EBIT $ 1,360 M
  • EBITDA $ 1,505 M
  • 60-Month Beta 1.72
  • Price/Sales 10.52
  • Price/Cash Flow 37.78
  • Price/Book 28.35

Options Overview Details

View History
  • Implied Volatility 44.71% (-1.68%)
  • Historical Volatility 28.89%
  • IV Percentile 92%
  • IV Rank 84.58%
  • IV High 49.02% on 01/30/26
  • IV Low 21.07% on 08/12/25
  • Expected Move (DTE 25) 49.30 (8.37%)
  • Put/Call Vol Ratio 0.56
  • Today's Volume 139
  • Volume Avg (30-Day) 84
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 2,938
  • Open Int (30-Day) 2,867
  • Expected Range 539.95 to 638.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $3.42
  • Number of Estimates 7
  • High Estimate $3.48
  • Low Estimate $3.39
  • Prior Year $2.96
  • Growth Rate Est. (year over year) +15.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
548.51 +7.43%
on 03/31/26
605.82 -2.74%
on 04/08/26
+2.27 (+0.39%)
since 03/17/26
3-Month
548.51 +7.43%
on 03/31/26
709.23 -16.92%
on 01/21/26
-126.12 (-17.63%)
since 01/16/26
52-Week
402.85 +46.27%
on 04/21/25
769.98 -23.47%
on 11/26/25
+177.76 (+43.20%)
since 04/17/25

Most Recent Stories

More News
IDEXX Laboratories to Release 2026 First Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the...

IDXX : 589.25 (+3.39%)
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

Helping clinicians investigate sooner and plan next steps with confidence

IDXX : 589.25 (+3.39%)
Is IDEXX Laboratories Stock Outperforming the S&P 500?

Despite outperforming the broader S&P 500 Index over the past year, analysts maintain a cautiously optimistic outlook on IDEXX Laboratories’ future prospects.

$SPX : 7,126.06 (+1.20%)
ZTS : 122.38 (+2.81%)
IDXX : 589.25 (+3.39%)
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

Although Thermo Fisher Scientific stock has declined over the past year, it has slightly outperformed other medical device stocks, and analysts remain highly bullish about its prospects.

TMO : 526.60 (+2.05%)
IDXX : 589.25 (+3.39%)
IHI : 54.22 (+1.86%)
Are Wall Street Analysts Bullish on IDEXX Laboratories Stock?

IDEXX Laboratories has outperformed the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

XLV : 148.80 (+1.49%)
$SPX : 7,126.06 (+1.20%)
IDXX : 589.25 (+3.39%)
IDEXX Laboratories to Present at Two Institutional Investor Conferences

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February...

IDXX : 589.25 (+3.39%)
Stocks Climb as Solid US Manufacturing News Bolsters Economic Optimism

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.73%. March E-mini S&P...

ALK : 45.40 (+10.33%)
MSTR : 166.52 (+11.80%)
TER : 380.38 (+3.95%)
RRC : 41.71 (-1.32%)
SNDK : 920.99 (+0.17%)
GLXY : 25.84 (+5.77%)
COIN : 206.33 (+3.26%)
OXY : 53.79 (-5.42%)
TSLA : 400.62 (+3.01%)
FANG : 180.27 (-3.42%)
STX : 547.75 (+3.00%)
WDC : 372.52 (+2.99%)
Stocks Gain on US Manufacturing Strength

The S&P 500 Index ($SPX ) (SPY ) today is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.84%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.64%. March E-mini S&P futures (ESH26...

MSTR : 166.52 (+11.80%)
TER : 380.38 (+3.95%)
SNDK : 920.99 (+0.17%)
CVX : 183.99 (-2.21%)
GLXY : 25.84 (+5.77%)
TXN : 229.82 (+3.01%)
$IUXX : 26,672.43 (+1.29%)
COIN : 206.33 (+3.26%)
ZNM26 : 111-165 (-0.18%)
CRML : 12.56 (+35.49%)
OXY : 53.79 (-5.42%)
TSLA : 400.62 (+3.01%)
Stock Indexes Climb as Chip Makers and AI Infrastructure Stocks Rebound

The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.42%. March E-mini S&P futures (ESH26...

MSTR : 166.52 (+11.80%)
SNDK : 920.99 (+0.17%)
CVX : 183.99 (-2.21%)
GLXY : 25.84 (+5.77%)
$IUXX : 26,672.43 (+1.29%)
COIN : 206.33 (+3.26%)
ZNM26 : 111-165 (-0.18%)
CRML : 12.56 (+35.49%)
OXY : 53.79 (-5.42%)
ESM26 : 7,119.00 (-0.59%)
FANG : 180.27 (-3.42%)
STX : 547.75 (+3.00%)
Idexx: Q4 Earnings Snapshot

Idexx: Q4 Earnings Snapshot

IDXX : 589.25 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 613.87
2nd Resistance Point 604.20
1st Resistance Point 596.72
Last Price 589.25
1st Support Level 579.57
2nd Support Level 569.90
3rd Support Level 562.42

See More

52-Week High 769.98
Fibonacci 61.8% 629.74
Last Price 589.25
Fibonacci 50% 586.41
Fibonacci 38.2% 543.09
52-Week Low 402.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.